Cryo Cell International PE ratio CCEL

Share price divided by earnings per share over the last twelve months, since 2014.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 480×; Jul 2025
9-year median: 24.1×
9-year range: 9.2× to 485×
Peer median: 12.8×

Cryo Cell International has no meaningful PE ratio today: it lost $0.23 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Jul 2025, at 480×.

On the days it had one over the last 9 years, its median was 24.1×, from 9.2× in Mar 2023 to 485× in May 2025.

PE ratio over time

median 24.1×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	480×	109×	485×
2024	16.2×	16.2×	19.5×
2023	19.2×	9.2×	28.9×
2022	26.4×	18.2×	37.5×
2021	24.7×	18.4×	28.9×
2020	19.3×	16.6×	26.6×
2019	25.8×	25.8×	49.4×
2018	24.2×	24.2×	29.4×
2017	29.3×	22.9×	29.3×
2016	n/m a value too high to mean anything
2015	85.5×	37.5×	86.8×
2014	48.2×	41.3×	139×

Against its peers

Companies in Healthcare nearest Cryo Cell International's size, closest first, today.

Company	PE ratio
CCELCryo Cell International	n/m
NEPHNephros	22.1×
ATNMActinium Pharmaceuticals	4.2×
APTAlpha Pro Tech	13.6×
SPROSpero Therapeutics	10.1×
LFVNLifevantage	14.7×
ICCCImmucell	128×
KEQUKewaunee Scientific	11.9×
PDEXPro DEX	15.1×
PLXProtalix BioTherapeutics	11.1×
NATRNatures Sunshine Products	12.0×
Peer median	12.8×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Cryo Cell International

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.